Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
DexCom, Inc.
DXCM · SEC Filings
website
11.1K
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and market...
Price
81.07
Market Cap
30.24 B
Float
371.59 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about DXCM
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
DexCom, Inc.
DXCM · SEC Filings
371.59 M
Float
81.07
Price
30.24 B
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025
News
TYPE
HEADLINE
FILED AT
8-K
Dexcom Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance
Oct 29, 2026
8-K
Dexcom Appoints Jereme Sylvain as EVP, Chief Operating Officer and Chief Financial Officer
Sep 14, 2026
8-K
Dexcom Appoints Glenn Boehnlein to Board of Directors
Sep 10, 2026
8-K
Dexcom Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance
Jul 30, 2026
8-K
DexCom, Inc. Announces Results of 2026 Annual Meeting of Stockholders
May 28, 2026
8-K
Dexcom Announces 2030 Financial Targets and New $1 Billion Share Repurchase Program
May 14, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
2,025,036 Shares of Common Stock-
Nov 22, 2021
424B5
3,865,979 Shares of Common Stock
Nov 21, 2018
424B2
4,700,000 Shares
May 5, 2011
424B2
2,850,000 Shares
Nov 9, 2010
424B2
3,500,000 Shares
Jan 15, 2010
424B5
15,994,000 Shares
Jan 30, 2009
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
May 9, 2025
S-3ASR
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 18, 2025
S-3ASR
Common Stock-
Nov 22, 2021
S-8 POS
Registration
Feb 10, 2021
S-8 POS
Registration
Feb 10, 2021
S-8 POS
Registration
Feb 10, 2021
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 15, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 15, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
May 2, 2025
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 27, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Mar 27, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 22, 2024
Ownerships
TYPE
HEADLINE
FILED AT
4
Ashley Euan A. (Reporting)
Nov 3, 2026
4
Stern Sadie (Reporting)
Oct 28, 2026
144
Form 144 - Report of proposed sale of securities
Oct 27, 2026
4
Brown Michael Jon (Reporting)
Oct 19, 2026
144
Form 144 - Report of proposed sale of securities
Oct 15, 2026
4
Stern Sadie (Reporting)
Sep 30, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
SD
Form SD - Specialized disclosure report
May 28, 2026
SD
Form SD - Specialized disclosure report
May 29, 2025
SD
Form SD - Specialized disclosure report
May 29, 2024
SD
Form SD - Specialized disclosure report
May 31, 2023
SD
Form SD - Specialized disclosure report
May 31, 2022
LETTER
Form UPLOAD - SEC-generated letter
May 5, 2022
